In this study, we discovered that CCL2 is significantly overexpressed in ESCC tumor tissues, and its high expression is closely associated with advanced TNM staging and poor survival prognosis, confirming its oncogenic role in ESCC [14, 27]. This evidence concerns the gene CCL2 and esophageal squamous cell carcinoma.